Literature DB >> 14505114

Evolution of the brain tumour spheroid model: transcending current model limitations.

A Corcoran1, L I F De Ridder, D Del Duca, O J P Kalala, T Lah, G J Pilkington, R F Del Maestro.   

Abstract

Tumour recurrence and the high mortality and morbidity associated with malignant brain tumours may be attributed to the failure of current therapeutic modalities (surgery, radiation and chemotherapy) to control the invasion of malignant brain tumour cells into healthy brain tissue. Several in vitro and in vivo models have been developed and used to study brain tumour invasion and cell motility. Here, we review some of the traditional in vitro models of brain tumour invasion and the latest adaptations to the widely used spheroid model. Several research groups studying the mechanisms mediating brain tumour invasion have made important contributions to the field by improving in vitro models of tumour migration and invasion. Sharing these advances will hopefully accelerate experimental discovery and the development of novel anti-invasion brain tumour therapies.

Entities:  

Mesh:

Year:  2003        PMID: 14505114     DOI: 10.1007/s00701-003-0096-0

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  4 in total

1.  Progression of astrocytomas and meningiomas: an evaluation in vitro.

Authors:  L Maes; J P O Kalala; M Cornelissen; L de Ridder
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

Review 2.  Cancer stem cells in the mammalian central nervous system.

Authors:  G J Pilkington
Journal:  Cell Prolif       Date:  2005-12       Impact factor: 6.831

3.  Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro.

Authors:  Boris Gole; María Beatriz Durán Alonso; Vincenc Dolenc; Tamara Lah
Journal:  Pathol Oncol Res       Date:  2009-05-13       Impact factor: 3.201

4.  Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr.

Authors:  Carlos A Fedrigo; Ivana Grivicich; Daniel P Schunemann; Ivan M Chemale; Daiane dos Santos; Thais Jacovas; Patryck S Boschetti; Geraldo P Jotz; Aroldo Braga Filho; Adriana B da Rocha
Journal:  Radiat Oncol       Date:  2011-11-11       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.